Epistaxis-overview and current aspects

xlomafota13 shared this article with you from Inoreader Epistaxis-overview and current aspects Via hno HNO. 2021 Oct 13. doi: 10.1007/s00106-021-01110-4. Online ahead of print. ABSTRACT Nosebleeds (epistaxis) are usually minor. Medical intervention is only necessary in about 6% of cases. The source of bleeding is frequently located in the anterior region of the nose (Kiesselbach's plexus). The estimated lifetime prevalence of epistaxis is 60%. Diffuse epistaxis is often a manifestation of systemic disease. Epistaxis is the leading symptom of Rendu-Osler-Weber disease (hereditary hemorrhagi c telangiectasia, HHT). If intervention is required, the first-choice of treatment is bidigital compression for several minutes. Common therapeutic measures include local hemostasis using electrocoagulation or chemical agents, e.g., silver nitrate. Resorbable anterior nasal tampons or tampons with a smooth surface are also frequently employed. In case of failed surgical closure of the sphenopalatine artery, angiographic embolization is the method of choice. PMID:34643746 | DOI:10.1007/s00106-021-01110-4 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.